abstract |
Compounds of formula (I): in free or salt or solvate form, where X, R 1 , R 2 , R 3 and R 4 have the meanings as indicated in the specification, are useful for treating diseases mediated by the ALK-5 and/or ALK-4 receptor. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described. |